The Society of Gynecologic Oncology (SGO)’s 50th Annual Meeting on Women’s Cancer will take place from Saturday, March 16, through Tuesday, March 19, 2019, in Honolulu, Hawaii.

In commemoration of the meeting’s 50th anniversary, medical oncologists, pathologists, radiation oncologists, hematologists, surgical oncologists, obstetrician/gynecologists, nurses, physician assistants, fellows in training, residents, and social workers will be presented with the latest scientific advances in the chemotherapy, radiation therapy, surgery, and palliative care for patients with gynecologic malignancies.

The scientific committee for the meeting, co-chaired by Wendy Brewster, MD, PhD from University of North Carolina at Chapel Hill School of Medicine, and S. Diane Yamada, MD from The University of Chicago in Illinois, sought to include both national and international original scientific research for presentation in various sessions across the 4-day meeting. To that end, meeting sessions will be aimed at identifying and explaining the latest trends in global research, methods, and technology in the treatment of gynecologic cancers and interpreting contemporary research findings on the prevention of and screening for gynecologic cancers. Expert presenters will examine the significance of novel approaches to the medical and surgical management of gynecologic cancers within the context of the current standard of care with an emphasis on evidence-based integration of new therapies into clinical practice across the clinical care team.

Continue Reading

Cancer Therapy Advisor’s coverage will feature reporting on the research presented during the scientific plenaries entitled Snap, Crackle, PARP; Challenges in Cancer Care Delivery; Coming Attractions: Clinical Trials; Operations Matter, Improving Efficiency; and Immunotherapy: Treatment, Trials, Toxicity. Oral abstract sessions on health outcomes and disparities and late-breaking abstracts will also be covered.

Visit Cancer Therapy Advisor’s conference section for continuous coverage from SGO’s Annual Meeting on Women’s Cancer.